ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

Black Physicians, Community Group To work With NCI

April 21, 1989

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

April 1, 1994

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997